Pricing & Access Solutions in APAC and Emerging Markets for the Pharma and MedTech sectors

Achieving your desired business impact for a drug or device in Asia Pacific, Latin America and other emerging markets requires an innovative approach to market access as well as effective implementation. We can help with both devising the right access and commercial strategy and supporting local teams in their execution, ensuring that your access-related goals are met.

Whether your challenge is how to maximise funding and accelerate timelines in reimbursed settings or maximising self-pay opportunities in out-of-pocket settings, we have the experience and local market network to provide you with the insights you need to make better informed decisions.

Latest News

We're hiring - get in touch to find out more

We’re looking for candidates both at entry level (analyst) and at senior consultant, based either in the UK or in Asia (we’re flexible on location).

Email us at to find out more



Pharmaceutical Pricing Research In Emerging Markets: It’s Not Just About The Numbers

A comprehensive out-of-pocket market access strategy is one of the critical cornerstones of launch into emerging markets.

Given the time lag in emerging market governmental agencies reimbursing innovative drugs and devices, out-of-pocket segments constitute an important business source in the first years after launch.

Read our full article here:

Pricing & Reimbursement of Specialty Drugs in Asian Markets

At Ispor Singapore 2016 we presented a poster on the P&R status of specialty medicines across key Asian markets.

You can see the abstract here:

If you’d like to discuss ways of maximising the access opportunities for your specialty brand, then drop us a line at

EMAX Solutions is a flexible and easy-to-work-with provider that is able to leverage expertise in developed markets to uncover meaningful insights in emerging markets. EMAX Solutions' work is high quality and has been widely used in my organisation and is a continuous input in to other projects.
Johannes Gambari, Snr. Pricing & Access Manager, Takeda Emerging Markets
We engaged EMAX Solutions to work on a complex aspect of pricing policy in Asia. This is not an easy area, since most of the times the processes are not formal and transparent. EMAX Solutions was able to navigate through the complexities to come up with good insights and recommendations that will help us make better informed decisions
APAC Pricing & HTA Lead, Swiss pharma manufacturer